|
|
|||||||||||
The British Journal of Psychiatry 142: 265-275 (1983)
© 1983 The Royal College of Psychiatrists
DS Charney, GR Heninger and DE Sternberg
It has been hypothesized that the mechanism of action of antidepressant treatments is related to their ability to decrease the sensitivity of the alpha-2 adrenergic autoreceptor. In order to assess alpha- adrenergic autoreceptor sensitivity, the effects of clonidine, the alpha-2 adrenergic receptor agonist, on plasma levels of the norepinephrine metabolite 3-methoxy-4-hydroxyphenethyleneglycol (MHPG), blood pressure (BP) and patient-rated sedation were measured in nine depressed patients before and during amitripytline treatment. Postsynaptic alpha-2 adrenergic receptor sensitivity was assessed by determining the growth hormone (GH) response to clonidine before and during treatment. Amitriptyline significantly attenuated the effects of clonidine on plasma MHPG, standing systolic BP, and sedation, indicating that alpha-2 adrenergic autoreceptors had become subsensitive. In addition, baseline plasma MHPG levels were significantly reduced. Amitriptyline had no effect on the GH response to clonidine.
This article has been cited by other articles:
![]() |
J. G. Modell, S. Boyce, E. Taylor, and C. Katholi Treatment of Atopic Dermatitis and Psoriasis Vulgaris With Bupropion-SR: A Pilot Study Psychosom Med, September 1, 2002; 64(5): 835 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kimber, C. J. Mathias, A. J. Lees, K. Bleasdale-Barr, H. S. Chang, A. Churchyard, and L. Watson Physiological, pharmacological and neurohormonal assessment of autonomic function in progressive supranuclear palsy Brain, July 1, 2000; 123(7): 1422 - 1430. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Nutt and P. Glue Imipramine in panic disorder. 2. Effects on {alpha}2-adrenoceptor function J Psychopharmacol, January 1, 1991; 5(2): 135 - 141. [Abstract] [PDF] |
||||
![]() |
P. Glue, D. Nutt, and P. Glue Clonidine challenge testing of alpha-2-adrenoceptor function in man: the effects of mental illness and psychotropic medication J Psychopharmacol, January 1, 1988; 2(3-4): 119 - 137. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |